Akyuz, F. Et Al. 2019. Inflammatory bowel disease and mycobacteria: how much can we trust isoniazid prophylaxis during antitumor necrosis factor therapy?. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY , vol.31, no.7 , 777-780.

Akyuz, F., Cavus, B., Iliaz, R., Soyer, O. M., Ormeci, A., Evirgen, S., ... Onder, S.(2019). Inflammatory bowel disease and mycobacteria: how much can we trust isoniazid prophylaxis during antitumor necrosis factor therapy?. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY , vol.31, no.7, 777-780.

Akyuz, Filiz Et Al. "Inflammatory bowel disease and mycobacteria: how much can we trust isoniazid prophylaxis during antitumor necrosis factor therapy?," EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY , vol.31, no.7, 777-780, 2019

Akyuz, Filiz Et Al. "Inflammatory bowel disease and mycobacteria: how much can we trust isoniazid prophylaxis during antitumor necrosis factor therapy?." EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY , vol.31, no.7, pp.777-780, 2019

Akyuz, F. Et Al. (2019) . "Inflammatory bowel disease and mycobacteria: how much can we trust isoniazid prophylaxis during antitumor necrosis factor therapy?." EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY , vol.31, no.7, pp.777-780.

@article{article, author={Filiz AKYÜZ Et Al. }, title={Inflammatory bowel disease and mycobacteria: how much can we trust isoniazid prophylaxis during antitumor necrosis factor therapy?}, journal={EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY}, year=2019, pages={777-780} }